Index S&P 500 P/E 25.86 EPS (ttm) 3.62 Insider Own 0.11% Shs Outstand 1.28B Perf Week 0.72%
Market Cap 120.14B Forward P/E 15.41 EPS next Y 6.08 Insider Trans -0.25% Shs Float 1.28B Perf Month 1.83%
Enterprise Value 140.86B PEG 4.37 EPS next Q 1.31 Inst Own 86.47% Short Float 1.03% Perf Quarter 7.32%
Income 4.66B P/S 3.51 EPS this Y 2.51% Inst Trans 0.13% Short Ratio 1.80 Perf Half Y 0.63%
Sales 34.20B P/B 2.51 EPS next Y 8.00% ROA 5.16% Short Interest 13.23M Perf YTD 17.25%
Book/sh 37.36 P/C 14.79 EPS next 5Y 5.92% ROE 9.72% 52W High 96.25 -2.69% Perf Year 3.66%
Cash/sh 6.33 P/FCF 22.65 EPS past 3/5Y -1.03% 0.39%ROIC 6.29% 52W Low 79.29 18.12% Perf 3Y 6.57%
Dividend Est. 2.77 (2.96%) EV/EBITDA 15.20 Sales past 3/5Y 1.91% 3.01% Gross Margin 59.81% Volatility 2.10% 1.85% Perf 5Y -10.44%
Dividend TTM 2.81 (3.00%) EV/Sales 4.12 EPS Y/Y TTM 22.08% Oper. Margin 18.47% ATR (14) 1.73 Perf 10Y 35.78%
Dividend Ex-Date Sep 26, 2025 Quick Ratio 1.50 Sales Y/Y TTM 4.98% Profit Margin 13.63% RSI (14) 55.42 Recom 2.18
Dividend Gr. 3/5Y 3.57% 5.33% Current Ratio 2.01 EPS Q/Q 0.54% SMA20 1.07% Beta 0.79 Target Price 98.33
Payout 77.47% Debt/Eq 0.60 Sales Q/Q 8.38% SMA50 2.35% Rel Volume 0.36 Prev Close 94.03
Employees 95000 LT Debt/Eq 0.55 Earnings Aug 19 BMO SMA200 6.78% Avg Volume 7.33M Price 93.66
IPO Nov 21, 1977 Option/Short Yes / Yes EPS/Sales Surpr. 2.53% 2.38% Trades
Volume 1,307,358 Change -0.39%
Date
Action
Analyst
Rating Change
Price Target Change
Jun-30-25 Upgrade Wolfe Research
Underperform → Peer Perform
Jun-16-25 Initiated Leerink Partners
Outperform
$110
Mar-04-25 Upgrade Citigroup
Neutral → Buy
$92 → $107
Oct-10-24 Upgrade RBC Capital Mkts
Sector Perform → Outperform
$98 → $105
Aug-21-24 Reiterated Oppenheimer
Perform
$92 → $94
Aug-15-24 Upgrade UBS
Sell → Neutral
$76 → $90
Aug-14-24 Downgrade Stifel
Buy → Hold
$100 → $85
May-30-24 Initiated Goldman
Sell
$83
Jul-19-23 Initiated Robert W. Baird
Neutral
$90
Jun-30-23 Initiated CL King
Buy
$106
May-30-23 Upgrade Morgan Stanley
Equal-Weight → Overweight
$104
Apr-24-23 Upgrade Wells Fargo
Equal Weight → Overweight
$77 → $100
Mar-29-23 Downgrade UBS
Buy → Sell
$127 → $79
Jan-09-23 Downgrade RBC Capital Mkts
Outperform → Sector Perform
$102 → $89
Nov-23-22 Downgrade Oppenheimer
Outperform → Perform
$106 → $85
Nov-23-22 Downgrade Citigroup
Buy → Neutral
$108 → $85
Nov-16-22 Downgrade Deutsche Bank
Buy → Hold
$85
Oct-18-22 Initiated Barclays
Equal Weight
$90
Oct-13-22 Initiated Mizuho
Buy
$100
Oct-12-22 Initiated Jefferies
Hold
$87
Show Previous Ratings
Today 09:01AM
09:00AM
Sep-14-25 02:03PM
Sep-13-25 05:54AM
Sep-11-25 07:57AM
06:30AM
Loading…
06:30AM
Sep-10-25 08:56AM
07:20AM
06:20AM
04:53AM
Sep-05-25 09:45AM
08:50AM
06:05AM
06:00AM
Sep-04-25 02:20PM
12:15PM
Loading…
12:15PM
06:00AM
Sep-03-25 08:49AM
05:55AM
02:55AM
Sep-02-25 11:13AM
11:06AM
08:45AM
Sep-01-25 12:11PM
Aug-30-25 04:05AM
Aug-29-25 11:22AM
07:00AM
Aug-28-25 03:17PM
08:48AM
Aug-26-25 09:50AM
05:41PM
Loading…
Aug-25-25 05:41PM
05:00AM
04:04AM
Aug-24-25 11:14AM
Aug-23-25 07:00AM
Aug-22-25 09:53AM
08:12AM
04:10AM
Aug-21-25 04:29PM
08:15AM
08:05AM
08:05AM
Aug-20-25 06:06PM
04:18PM
11:20AM
10:30AM
10:30AM
10:15AM
09:40AM
09:20AM
08:05AM
03:03AM
Aug-19-25 05:01PM
04:33PM
04:25PM
(The Wall Street Journal)
04:02PM
(Investor's Business Daily)
03:41PM
02:59PM
01:45PM
(The Wall Street Journal)
12:21PM
12:05PM
12:01PM
11:40AM
11:21AM
09:48AM
09:45AM
09:35AM
(The Wall Street Journal)
09:30AM
09:10AM
(Investor's Business Daily)
08:46AM
08:39AM
08:36AM
07:55AM
07:41AM
07:27AM
07:26AM
06:52AM
(Associated Press Finance)
06:46AM
06:45AM
06:32AM
05:59AM
05:45AM
(The Wall Street Journal)
04:57AM
04:05AM
03:14AM
(The Wall Street Journal)
Aug-18-25 04:31PM
Aug-17-25 07:35AM
Aug-15-25 04:32PM
04:32PM
10:00AM
Aug-14-25 06:00PM
05:45PM
04:15PM
10:25AM
09:15AM
08:33AM
06:00AM
04:04AM
Aug-13-25 09:21AM
08:37AM
Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment includes products for the diagnosis, treatment, and management of cardiac rhythm disorders and cardiovascular disease. The Neuroscience Portfolio is made up of cranial and spinal technologies, specialty therapies, and neuromodulation divisions. The Medical Surgical Portfolio is comprised of surgical innovations and respiratory, gastrointestinal, and renal divisions. The Diabetes Group segment offers insulin pumps, continuous glucose monitoring systems, and insulin pump consumables. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
KIIL HARRY SKIP EVP & President Cardiovascular Sep 03 '25 Sale 91.58 8,605 788,048 35,615 Sep 05 04:18 PM KIIL HARRY SKIP Officer Sep 03 '25 Proposed Sale 91.58 8,605 788,049 Sep 03 03:23 PM Jellison William R Director Aug 22 '25 Buy 92.73 2,500 231,825 2,500 Aug 25 05:18 PM Jellison William R Director Aug 25 '25 Buy 92.37 2,500 230,925 5,000 Aug 25 05:18 PM Walter Matthew R. SVP, Chief HR Officer Aug 01 '25 Option Exercise 23.91 3,142 75,114 32,804 Aug 04 04:21 PM Wall Brett A. EVP & Pres Neuroscience Aug 01 '25 Option Exercise 0.00 15,249 0 66,531 Aug 04 04:20 PM Smith Gregory L EVP Global Ops & Supply Chain Aug 01 '25 Option Exercise 0.00 11,328 0 83,071 Aug 04 04:19 PM Martha Geoffrey Chairman and CEO Aug 01 '25 Option Exercise 32.21 98,324 3,166,800 284,923 Aug 04 04:18 PM Marinaro Michael EVP, Pres MedSurg and Americas Aug 01 '25 Option Exercise 25.24 9,661 243,828 57,628 Aug 04 04:17 PM KIIL HARRY SKIP EVP & President Cardiovascular Aug 01 '25 Option Exercise 0.00 10,457 0 51,775 Aug 04 04:16 PM Blomquist Denise L. Chief Accounting Officer Aug 01 '25 Option Exercise 32.22 518 16,692 12,671 Aug 04 04:15 PM Salmon Sean Officer Jun 06 '25 Proposed Sale 86.81 18,378 1,595,469 Jun 06 02:43 PM Walter Matthew R. SVP, Chief HR Officer Jan 27 '25 Option Exercise 74.84 1,337 100,061 26,997 Jan 28 05:10 PM Marinaro Michael EVP & President, Surgical OU Jan 27 '25 Option Exercise 74.84 2,345 175,500 43,323 Jan 28 05:09 PM Martha Geoffrey Chairman and CEO Jan 27 '25 Option Exercise 74.84 34,741 2,600,016 216,954 Jan 28 05:07 PM Wall Brett A. EVP & Pres Neuroscience Jan 24 '25 Option Exercise 78.00 12,437 970,086 53,416 Jan 27 05:35 PM Wall Brett A. EVP & Pres Neuroscience Jan 24 '25 Sale 90.00 12,437 1,119,330 40,979 Jan 27 05:35 PM Wall Brett A. Officer Jan 24 '25 Proposed Sale 90.00 12,437 1,119,330 Jan 24 02:34 PM Wall Brett A. EVP & Pres Neuroscience Jan 08 '25 Option Exercise 74.84 6,850 512,654 50,558 Jan 10 04:48 PM Wall Brett A. EVP & Pres Neuroscience Jan 08 '25 Sale 80.41 9,850 792,038 40,708 Jan 10 04:48 PM Wall Brett A. Officer Jan 08 '25 Proposed Sale 80.41 9,850 792,038 Jan 08 09:52 AM PARKHILL KAREN L Former Director Oct 31 '24 Proposed Sale 89.73 30,000 2,691,794 Oct 31 03:21 PM PARKHILL KAREN L Former Director Oct 30 '24 Proposed Sale 90.58 15,000 1,358,740 Oct 30 04:11 PM PARKHILL KAREN L Former BOD Oct 29 '24 Proposed Sale 91.16 15,000 1,367,348 Oct 29 03:26 PM PARKHILL KAREN L Former Director Oct 24 '24 Proposed Sale 92.49 22,712 2,100,633 Oct 24 04:01 PM PARKHILL KAREN L Former Director Oct 23 '24 Proposed Sale 91.76 23,848 2,188,205 Oct 23 04:30 PM PARKHILL KAREN L Former BOD Oct 18 '24 Proposed Sale 91.74 48,825 4,479,310 Oct 18 04:24 PM PARKHILL KAREN L Former BOD Oct 17 '24 Proposed Sale 89.87 55,179 4,958,718 Oct 17 03:35 PM
